Appointments

Leading Edge, part of the Lucid Group specialising in strategic health communications and medical education, has...

UK-based antifungal drug discovery and development company F2G has appointed John Rex as Chief Medical Officer. Dr Rex...

Arquer Diagnostics has appointed Nadia Whittley as CEO with immediate effect. With significant experience in strategy,...

Mission Therapeutics has appointed Dr Colin Goddard as non-executive Chairman, effective January 1st 2017. Colin...

Publicis Health has appointed Victoria Wright (pictured) as Managing Director of Publicis LifeBrands (advertising),...

The new Medicines Discovery Catapult (MDC) has announced the appointment of Ed Owen to put medical research charities...

Anti-infectives company Auspherix has announced further strengthening of its management team, with Dr Neil Miller...

Helen Gordon will leave the RPS next year to become the Chief Executive of The Royal Society of Medicine. Helen...

Anke Linnartz has joined MorphoSys AG as Vice President and Head of Corporate Communications and Investor Relations....

Mereo BioPharma, a clinical stage, UK-based, biopharmaceutical company focused on rare and specialty diseases, has...

Artios Pharma, a newly launched private company focussed on developing novel cancer treatments targeting the DNA...

Targovax, a clinical stage company focused on developing and commercialising immuno-oncology therapies to target,...

Enterprise Therapeutics, a drug discovery company dedicated to the research and development of novel therapies for the...

Star has welcomed Ryan Wooller (pictured), as Business Development Director. Ryan joined the industry in 2003 and has...

Sygnature Discovery Limited, the UK's largest independent provider of integrated drug discovery resources and...